Roberto Ascione



Roberto Ascione

CEO, Healthware Group

Roberto is a pioneer in digital health and a recognized thought leader, people-inspiring founder, serial entrepreneur and global manager.Trained as a medical doctor and in marketing communications, his passion for medicine, computer science and human-technology interactions have led to his lifelong commitment and dedication to the advancement and spreading of digital healthcare,  he holds a strong belief that digital innovations and technology will be the most impactful drivers of change in healthcare.

Roberto is currently CEO at Healthware Group the largest, independent, healthcare consultancy (more than 700 people in Europe and USA through the Intouch Solutions joint venture) helping life sciences companies, healthcare stakeholders and start-ups navigate the transformation in healthcare, from strategy to technology.

Roberto is also very active in the digital health ecosystem in various advisor capacities both in Europe and in USA to companies, start-ups and investors; among others he has been recognized Best Industry Leader by The Health 2.0 - 10 Year Global Retrospective Awards in 2016, nominated Transformational Leader at The 2017 PM360 ELITE Awards and named among the 100 Most Inspiring People by PharmaVOICE in 2017. He is a regular keynoter at numerous conferences, has been President of the HealthTech Summit and is Chairman at Frontiers Health, which emerged as one of the leading digital health conferences globally. In the past 20 years Roberto has been focusing on marketing and communications, business transformation and innovation in health and wellness: between 1997 and 2006 founded multiple companies at the intersection of healthcare and technology with main exit to Publicis Groupe in 2007; held multiple roles at Publicis Healthcare up to 2013 as Global President at Razorfish Healthware leading a Team of 300+ in 9 countries. 

When not in New York City, London or Milan, then most likely, you will find him in Salerno along the Amalfi Coast, Italy.